Study protocol: baby-OSCAR trial: Outcome after Selective early treatment for Closure of patent ductus ARteriosus in preterm babies, a multicentre, masked, randomised placebo-controlled parallel group trial

Study protocol: baby-OSCAR trial: Outcome after Selective early treatment for Closure of patent ductus ARteriosus in preterm babies, a multicentre, masked, randomised placebo-controlled parallel group trial

<p><strong>BACKGROUND:</strong> The question of whether to treat patent ductus arteriosus (PDA) early or wait until symptoms appear remains high on the research agenda for neonatal medicine. Around 7000 extremely preterm babies under 29 weeks' gestation are born in...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Gupta, S, Juszczak, E, Hardy, P, Subhedar, N, Wyllie, J, Kelsall, W, Sinha, S, Johnson, S, Roberts, T, Hutchison, E, Pepperell, J, Linsell, L, Bell, JL, Stanbury, K, Laube, M, Edwards, C, Field, D, ‘The Baby-OSCAR Collaborative Group’
Format:	Journal article
Język:	English
Wydane:	BMC 2021

Podobne zapisy

Study protocol: baby-OSCAR trial: Outcome after Selective early treatment for Closure of patent ductus ARteriosus in preterm babies, a multicentre, masked, randomised placebo-controlled parallel group trial
od: Samir Gupta, i wsp.
Wydane: (2021-02-01)

Trial of selective early treatment of patent ductus arteriosus with ibuprofen
od: Gupta, S, i wsp.
Wydane: (2024)

Baby-OSCAR: Outcome after Selective early treatment for Closure of patent ductus ARteriosus in preterm babies—a statistical analysis plan for short-term outcomes
od: Bell, JL, i wsp.
Wydane: (2021)

Spontaneous closure of patent ductus arteriosus in preterm babies after failed attempts at transcatheter device closure
od: Ahmed Deniwar, i wsp.
Wydane: (2022-01-01)

Continued uncertainty regarding treatment of patent ductus arteriosus in premature infants and the role of clinical trials
od: Juszczak, E, i wsp.
Wydane: (2018)

Diameter of the ductus arteriosus as a predictor of patent ductus arteriosus (PDA)
od: Nowak Dariusz, i wsp.
Wydane: (2011-08-01)

Patency of the Ductus Arteriosus in Newborns: Experience in a Special Care Baby Unit.
od: Omokhodion SI, i wsp.
Wydane: (2024-07-01)

Percutaneous Device Closure of Ductus Arteriosus in a 1.3Kg Baby
od: Andaleeb Ara, i wsp.
Wydane: (2022-11-01)

Patent Ductus Arteriosus Clinical Trials: Lessons Learned and Future Directions
od: Aisling Smith, i wsp.
Wydane: (2021-01-01)

ENDOVASCULAR TREATMENT OF THE PATENT DUCTUS ARTERIOSUS
od: A. N. Pakholkov, i wsp.
Wydane: (2019-04-01)

ENDOVASCULAR TREATMENT OF THE PATENT DUCTUS ARTERIOSUS
od: A. N. Pakholkov, i wsp.
Wydane: (2019-04-01)

Subaortic membrane with patent ductus arteriosus
od: Nishes Basnet, i wsp.
Wydane: (2017-11-01)

Ibuprofen and paracetamol for patent ductus arteriosus
od: Carlo Dani
Wydane: (2014-09-01)

Patent Ductus Arteriosus in Preterm Infants
od: Jia-Yuh Chen
Wydane: (2012-10-01)

Percutaneous closure of patent ductus arteriosus with the Nit-Occlud® patent ductus arteriosus device in 268 consecutive cases
od: Andrii V Maksymenko, i wsp.
Wydane: (2019-01-01)

Arterial hemodynamics in patent ductus arteriosus stenting /
od: Fara Lyana Jamalruhanordin, 1990-, author, i wsp.
Wydane: (2015)

Management of Patent Ductus Arteriosus Endarteritis in Children
od: Jane Canning, i wsp.
Wydane: (2024-01-01)

Management of patent ductus arteriosus in premature infants.
od: A. Obolonskyi, i wsp.
Wydane: (2019-06-01)

Intravenous Paracetamol and Patent Ductus Arteriosus Closure
od: Herlina Dimiati, i wsp.
Wydane: (2020-01-01)

Unusual presentation for a patent ductus arteriosus
od: C. D. Vizza, i wsp.
Wydane: (2009-09-01)

Coronary fistula resembling patent ductus arteriosus
od: Sgarbieri Ricardo Nilsson, i wsp.
Wydane: (2003-01-01)

Aortobronchial fistula: Secondary to patent ductus arteriosus
od: Tan Sheng, i wsp.
Wydane: (2012-10-01)

Patent ductus arteriosus – not only apaediatric issue
od: Michał Jędrzejek, i wsp.
Wydane: (2014-09-01)

Outcome following patent ductus arteriosus ligation in premature infants: a retrospective cohort analysis
od: Yates Robert, i wsp.
Wydane: (2006-05-01)

Transcriptome Analysis Reveals Differential Gene Expression between the Closing Ductus Arteriosus and the Patent Ductus Arteriosus in Humans
od: Junichi Saito, i wsp.
Wydane: (2021-04-01)

Parametric study in patent ductus arteriosus (PDA) stenting /
od: Mohamad Faez Ayub, 1991-, author, i wsp.
Wydane: (2015)

Keeping the Ductus Arteriosus Patent: Current Strategy and Perspectives
od: Anastasios Chatziantoniou, i wsp.
Wydane: (2025-01-01)

Is Takotsubo syndrome induced by patent ductus arteriosus occlusion?
od: Shuhao Li, i wsp.
Wydane: (2024-03-01)

Obstacles to the Early Diagnosis and Management of Patent Ductus Arteriosus
od: Gowda SH, i wsp.
Wydane: (2024-02-01)

Gentamicin in neonates with hemodynamically significant patent ductus arteriosus
od: Kannan Sridharan, i wsp.
Wydane: (2023-01-01)

An aberrant patent ductus arteriosus mimicking aortopulmonary window
od: Hassan Aghajani, i wsp.
Wydane: (2019-12-01)

Diagnostic steps of a cat with patent ductus arteriosus
od: Meriç KOCATÜRK, i wsp.
Wydane: (2018-05-01)

Role of Echocardiography in Percutaneous Closure of Patent Ductus Arteriosus
od: Sujata S Alawani, i wsp.
Wydane: (2022-01-01)

Unusual Presentation of Patent Ductus Arteriosus in Elderly Patient
od: Slobodan V. Micovic, i wsp.
Wydane: (2020-01-01)

Evaluation the Effectiveness of Ibuprofen in Improving Patent Ductus Arteriosus
od: Maryam Beheshtifard, i wsp.
Wydane: (2021-09-01)

Dislodged device during closure of patent ductus arteriosus
od: Chaitali SenDasgupta, i wsp.
Wydane: (2011-01-01)

THE MODERN VIEW ON PATENT DUCTUS ARTERIOSUS IN PRETERM INFANTS
od: Жанна Анатольевна Звягина, i wsp.
Wydane: (2018-12-01)

Evaluation the Effectiveness of Ibuprofen in Improving Patent Ductus Arteriosus
od: Maryam Beheshtifard, i wsp.
Wydane: (2021-09-01)

Risk factors for patent ductus arteriosus in preterm neonates
od: Novia Bernati, i wsp.
Wydane: (2014-06-01)

Patent ductus arteriosus with a rare hand anomaly
od: Y Ramesh Bhat, i wsp.
Wydane: (2022-01-01)